Wednesday, October 06, 2010 6:57:52 PM
The fundamentals are sound.The science is solid and the professionals involved are sterling.
The share price currently of this stock is to be expected as all emerging companies face the gauntlet of shorters and rumors and so on.
This company also faces not only the above but also the resistance to change that also occurs when an old technology or system is being replaced.As stated before , people , comfortable in their positions,don't like being pushed out of it.They will resist.
Pharmaceutical companies with established therapies or therapies in the pipeline are going to use their influence in the FDA and professional circles (and maybe posters on stock boards)to try to derail threatening new technologies.
I don't expect you or others to take my word for it (nor do I want you to) but if you and others actually research NNVC and arrive at the conclusion(s) that I have , then buy with confidence and be prepared to withstand the negativity.
The therapies put forth by NNVC are totally unique and will have a devastating effect on the old technologies as well as returning spectacular rewards to the early investors.Taking over multi-billion dollar markets from old technologies.Are they afraid?They are very afraid and will resist.
When doubt sets in , always go back to the fundamentals and review your reasons for investing in the first place.Stand by your convictions and hold fast.
The "officers" at NNVC are not in this for nothing.They have put their lives,their money and reputations and professional standings on the line as well.Involving the likes of researchers like Harris and Rosenthal.We need to stand by them in this endeavour as they are our future.Don't let the thieves steal it.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM